% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • biglabowski99 biglabowski99 Feb 11, 2013 11:00 PM Flag

    Beyond Bevacizumab: Potential Agents for the Treatment of Ovarian Cancer

    Sorry if i post dups. I do not read every message on this thread but figure better to post than to not.

    Other agents have also shown promising data. Cabozantinib, an oral tyrosine kinase inhibitor, is being investigated in a number of different tumor types, including ovarian cancer. “That’s probably the most promising oral TKI for ovarian cancer, having shown the most pronounced response rates in early trials,” Konner said.

5.54-0.06(-1.07%)Jul 30 4:00 PMEDT